L-AP4

Source: Wikipedia, the free encyclopedia.
L-AP4
Clinical data
Other namesL-2-Amino-4-phosphonobutyric acid
Identifiers
  • (2S)-2-Amino-4-phosphonobutanoic acid
JSmol)
  • C(CP(=O)(O)O)[C@@H](C(=O)O)N
  • InChI=1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10)/t3-/m0/s1 ☒N
  • Key:DDOQBQRIEWHWBT-VKHMYHEASA-N ☒N
 ☒NcheckY (what is this?)  (verify)

L-AP4 (L-2-amino-4-phosphonobutyric acid) is a drug used in scientific research, which acts as a group-selective agonist for the group III metabotropic glutamate receptors (mGluR4/6/7/8). It was the first ligand found to act as an agonist selective for this group of mGlu receptors,[1] but does not show selectivity between the different mGluR Group III subtypes. It is widely used in the study of this receptor family and their various functions.[2][3][4][5]

References

This page is based on the copyrighted Wikipedia article: L-AP4. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy